Overview
Rufloxacin is a quinolone antibiotic.
Background
Rufloxacin is a quinolone antibiotic.
Indication
临床用于敏感菌引起的下呼吸道及尿道感染。如肺炎、急慢性支气管炎，急慢性肾盂肾炎，急性膀胱炎，尿道炎以及皮肤软组织化脓性感染。
Associated Conditions
- Acute Uncomplicated Bacterial Cystitis
- Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Rufloxacin Hydrochloride Tablets | 国药准字H20030023 | 化学药品 | 片剂 | 7/13/2020 | |
| Rufloxacin Hydrochloride Capsules | 国药准字H20030022 | 化学药品 | 胶囊剂 | 7/13/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||